中国保健营养
中國保健營養
중국보건영양
China Health Care & Nutrition
2015年
13期
24
,共1页
复方鳖甲软肝片%恩替卡韦%乙肝肝硬化%临床疗效
複方鱉甲軟肝片%恩替卡韋%乙肝肝硬化%臨床療效
복방별갑연간편%은체잡위%을간간경화%림상료효
Fufangbiejiaruanganpian%Liver cirrhosis%Clinical curative effect
目的 探讨复方鳖甲软肝片联合恩替卡韦治疗乙肝后肝硬化临床疗效. 方法 随机选取我院收治的100 例乙肝后肝硬化患者,分为观察组和对照组,各50例,对照组采用恩替卡韦进行治疗,观察组在对照组的基础上再结合复方鳖甲软肝片进行治疗. 结果 治疗后与治疗前相比,治疗后两组均在肝功能、血清肝纤维化指标及HBV-DNA上有很大的改善,且观察组在改善肝功能及血清纤维化指标的效果上由于对照组;观察组的治疗总有效率为94%,对照组为74%,差异具有统计学意义(P<0.05). 结论 复方鳖甲软肝片联合恩替卡韦能有效的改善肝硬化和控制肝病毒的复发,值得临床广泛应用.
目的 探討複方鱉甲軟肝片聯閤恩替卡韋治療乙肝後肝硬化臨床療效. 方法 隨機選取我院收治的100 例乙肝後肝硬化患者,分為觀察組和對照組,各50例,對照組採用恩替卡韋進行治療,觀察組在對照組的基礎上再結閤複方鱉甲軟肝片進行治療. 結果 治療後與治療前相比,治療後兩組均在肝功能、血清肝纖維化指標及HBV-DNA上有很大的改善,且觀察組在改善肝功能及血清纖維化指標的效果上由于對照組;觀察組的治療總有效率為94%,對照組為74%,差異具有統計學意義(P<0.05). 結論 複方鱉甲軟肝片聯閤恩替卡韋能有效的改善肝硬化和控製肝病毒的複髮,值得臨床廣汎應用.
목적 탐토복방별갑연간편연합은체잡위치료을간후간경화림상료효. 방법 수궤선취아원수치적100 례을간후간경화환자,분위관찰조화대조조,각50례,대조조채용은체잡위진행치료,관찰조재대조조적기출상재결합복방별갑연간편진행치료. 결과 치료후여치료전상비,치료후량조균재간공능、혈청간섬유화지표급HBV-DNA상유흔대적개선,차관찰조재개선간공능급혈청섬유화지표적효과상유우대조조;관찰조적치료총유효솔위94%,대조조위74%,차이구유통계학의의(P<0.05). 결론 복방별갑연간편연합은체잡위능유효적개선간경화화공제간병독적복발,치득림상엄범응용.
Objective To investigate the effect of compound Biejiaruangan tablets combined with entecavir treatment of hepatitis B cirrhosis clinical curative effect . Method in our hospital were 100 cases of hepatitis B liver cirrhosis patients were selected and divided into observation group and control group ,50 cases in each,while the control group was treated with en entecavir treatment observed group in the control group based on the combined with compound Biejiaruangan tablets for treatment . Results after treatment,the two groups showed great improvement in liver function ,serum liver fibrosis index and HBV -DNA,and the observation group was better than control group.The total effective rate was 92.4% in observation group and 75.6% in control group,the difference was statistically significant (P<0.05).Conclusion Fufang Biejia Ruangan tablets combined grace entecavir can effectively improve liver cirrhosis and hepatic virus recurrence .
